Study #2021-0758
Long-term Follow-up Study for Participants of Kite-Sponsored Interventional Studies Treated With Gene-Modified Cells
MD Anderson Study Status
Enrolling
Treatment Agent
Axicabtagene Ciloleucel, Brexucabtagene Autoleucel, Anitocabtagene autleucel, KITE-753, KITE-197, KITE-363
Description
The goal of this clinical study is to learn more about the long-term safety, effectiveness and prolonged action of Kite study drugs, axicabtagene ciloleucel, brexucabtagene autoleucel, KITE-363, KITE-753, KITE-197, and anitocabtagene autoleucel in participants of Kite-sponsored interventional studies.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Solid and Hematological Malignancies
Study phase:
Physician name:
Sattva Neelapu
Department:
Lymphoma/Myeloma
For general questions about clinical trials:
1-866-541-1846
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.